Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11526 posts found.

GSK image

GSK shingles vaccine performs

April 29, 2015 Research and Development, Sales and Marketing GSK, GlaxoSmithKline, HZ/su, Merck, zostovax

GlaxoSmithKline’s HZ/su vaccine candidate for the prevention of shingles has demonstrated promising benefits across all age groups in a late-stage …
News
Merck image

Conference round-up: companies go big on hepatitis C at EASL

April 29, 2015 Sales and Marketing Bristol-Myers Squibb, EASL, Merck, daclatasvir, daklinza

Big pharma names posted favourable results for hepatitis C treatments as they jostled for position as market leaders at the …
News
andreas_reimer_

RSA hires two consultants in Germany

April 29, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Andreas Reimer, Ji Kwon, rsa

Executive search and interims firm RSA has appointed two consultants to its teams in the DACH region. Andreas Reimer (pictured) …
Appointment

Helping Nepal – SHL to Match Staff Donations

April 29, 2015 Sales and Marketing helping nepal, shl group, world vision

In immediate response to the devastating earthquake that left Nepal in ruins on April 25th, SHL quickly reached out to …
News
Press release
BMS image

BMS lifted by new products

April 28, 2015 Sales and Marketing BMS, NICE, Q1, eams, immuno-oncology and hepatitis C

New drugs have helped Bristol-Myers Squibb see a slight increase in sales for the first quarter of 2015. Total revenues …
News
celgene-logo

Celgene splashes out on cancer R&D firm

April 28, 2015 Research and Development, Sales and Marketing

Oncology specialists Celgene have made a $485 million outlay to buy Quanticel Pharmaceuticals, to increase its effort and investment in …
News
The BioIndustry Association's Steve Bates

UK ‘has ten years to become global biotech leader’

April 28, 2015 Manufacturing and Production, Research and Development, Sales and Marketing

The UK should be home to ‘the third global cluster’ for biotech in the next 10 years, according to a …
News
teva_copy

M&A drama continues as Mylan rejects Teva

April 28, 2015 Sales and Marketing M&A, MA, Mylan, Perrigo, Teva, bids, generics, takeovers

Mylan has firmly rejected Teva’s acquisition bid, even though its own bid for Irish firm Perrigo has also been turned …
News
gilenya__novartis_multiple_sclerosis

Researchers hit out at ‘alarming’ increase in MS drug costs

April 27, 2015 Manufacturing and Production, Research and Development, Sales and Marketing

Researchers have hit out at the ‘alarming’ rise in the costs of disease-modifying treatments for multiple sclerosis, in a new …
News
EM HQ

Big-name generics among new CHMP recommendations

April 27, 2015 Sales and Marketing CHMP, EMA, European Medicines Agency, Lyrica, pregabalin

The EMA’s Committee for Medicinal Products for Human Use (CHMP) has recommended 11 new medicines for approval, among them several …
News
pillsphotos1

The Pharmafocus debate: Is the price of new hepatitis C treatments fair?

April 27, 2015 Research and Development, Sales and Marketing Doctors of the World, Drug pricing, EFPIA, Gilead, MSF, drug cost, hepatitis C, patents, sofosbuvir, sovaldi

YES – says Richard Bergström, director general of the European Federation of Pharmaceutical Industries and Associations (EFPIA), who argues that …
Feature
Opdivo

EMA approves BMS’ Opdivo for advanced skin cancer

April 27, 2015 Sales and Marketing BMS, Bristol-Myers Squibb, EMA, Merck, Yervoy, ipilimumab, keytruda, melanoma, nivolumab, opdivo, pembrolizumab, skin cancer

Bristol-Myers Squibb has earned a recommendation from the EMA for its cancer immunotherapy treatment Opdivo as a monotherapy for patients …
News
astrazeneca image

AstraZeneca looks to oncology match-ups to boost sales

April 24, 2015 Sales and Marketing AstraZeneca, Brilinta, Celgene, Innate, Juno, farxiga, ticagrelor

AstraZeneca posted a 1% increase in revenue in its first-quarter 2015 financials – and is investing the money to back …
News
Chief executive Peter George image

Clinigen buys Idis for £225 million

April 24, 2015 Sales and Marketing CBPE Capital, Clinigen, IDIS, unlicensed

UK speciality pharma group Clinigen is paying £225 million to acquire the Surrey-based unlicensed supplier of medicines firm Idis. Unlicensed …
News
charlie-mayr_1

Actavis confirms retirement of its comms officer

April 24, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actavis, charles mayr

Ireland-based pharma firm Actavis has announced its chief communications officer Charles Mayr (pictured) is to retire shortly due to health …
Appointment
The Gateway to Local Adoption Series

Latest content

China approves fruquintinib combination for kidney cancer

May 29, 2026

BIOTRONIK, Charité and GHCF launch digital cardiology partnership

May 28, 2026

Endometriosis study begins recruitment in UK hospitals

May 28, 2026

MHRA authorises donidalorsen for hereditary angioedema prevention

May 27, 2026

Partnership aims to expand early access to medicines

May 26, 2026